Results 51 to 60 of about 319 (119)

The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses? [PDF]

open access: yes, 2019
Fungal infections have aroused much interest over the last years because of their involvement in several human diseases. Immunocompromission due to transplant-related therapies and malignant cancer treatments are risk factors for invasive fungal ...
Emanuele Marra   +9 more
core   +1 more source

Терапевтична ефективність 1-[4-(1,1,3,3-тетраметилбутил)фенокси]-3-(n-бензилгексаметиленіміній)-2-пропанол хлориду in vivo [PDF]

open access: yes, 2017
The aim of the research was to determine the therapeutic efficacy of the derivative of arilalifatic aminopropanols 1-[4-(1,1,3,3-tetramethyl butyl)phenoxi]-3-(N-benzyl hexamethylenimino)-2-propanol chloride (compound КВМ-194) in experiments in vivo on ...
Suvorova, Zinaida
core   +3 more sources

Epidemiology, treatment options and outcome of invasive infections caused by Aspergillus section Usti [PDF]

open access: yes, 2020
Background. Aspergillus spp. of section Usti (A. ustus) represent a rare cause of invasive aspergillosis (IA). This multicenter study describes the epidemiology and outcome of A. ustus infections. Methods. Patients with A.
GLAMPEDAKIS, Emmanouil
core  

Nuevos tratamientos para la candidiasis oral [PDF]

open access: yes, 2021
La candidiasis oral (CO) es una de las infecciones fúngicas más comunes que aparece en la cavidad oral. Su principal agente causal es la Candida, un hongo oportunista que se encuentra en la flora oral normal. Sin embargo, en ocasiones puede ocurrir un
Baloco Núñez, Sara Fernanda
core  

Additional file 2 of Review of the novel antifungal drug olorofim (F901318)

open access: yes
Supplementary Material ...
Vanbiervliet, Yuri   +5 more
openaire   +1 more source

Terapêutica antifúngica: novas moléculas, novas formas de administração e diferentes estratégias para alcançar a toxicidade seletiva [PDF]

open access: yes, 2021
Nos últimos anos verificou-se um aumento das infeções fúngicas invasivas, devido ao aumento da esperança de vida e do número de doentes imunodeprimidos e ao aparecimento de resistência aos antifúngicos.
Moreira, Marta Alexandra Macedo
core  

Cryptococcus Penyebab Kriptokokosis dan Berbagai Aspek Penting [PDF]

open access: yes, 2023
Pada bulan Oktober 2022 WHO meluncurkan WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action yang antara lain memuat daftar jamur patogen yang dapat menyebabkan penyakit pada manusia.
Adawiyah, Robiatul   +4 more
core  

Bridging the gap to non-toxic fungal control: lupinus-derived blad-containing ologomer as a novel candidate to combat human pathgenic fungi [PDF]

open access: yes, 2017
Original ResearchThe lack of antifungal drugs with novel modes of action reaching the clinic is a serious concern. Recently a novel antifungal protein referred to as Blad-containing oligomer (BCO) has received regulatory approval as an agricultural ...
Aerts   +65 more
core   +2 more sources

Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study

open access: yes
BackgroundOnly a small number of antifungal therapies for invasive fungal disease (IFD) are currently available, and many pathogens are resistant to one or more of these therapies. Olorofim, the first orotomide antifungal agent to be developed, is active
Aguado, Jose Maria   +53 more
core   +2 more sources

Estudio de la resistencia a los antifúngicos en hongos patógenos humanos [PDF]

open access: yes, 2019
Las mejoras en el diagnóstico, el tratamiento y el cuidado de pacientes inmunodeprimidos han incrementado su tasa de supervivencia, pero también han dado lugar al aumento progresivo de otras enfermedades, como las infecciones fúngicas invasoras.
Rivero Menéndez, Olga
core   +1 more source

Home - About - Disclaimer - Privacy